AMENDED AND RESTATED LICENSE AGREEMENTLicense Agreement • May 11th, 2015 • Coherus BioSciences, Inc. • Biological products, (no disgnostic substances) • New York
THIS AMENDED AND RESTATED LICENSE AGREEMENT (the “Agreement”) is made and entered into as of April 10, 2015 (the “Effective Date”) among COHERUS BIOSCIENCES, INC., a Delaware corporation with a principal place of business at 201 Redwood Shores Parkway, Suite 200, Redwood City, California 94065, United States of America (“Coherus”), on the one hand, and BAXTER INTERNATIONAL, INC., a Delaware corporation with a principal place of business at 1 Baxter Parkway, Deerfield, IL 60015, United States of America (“BII”), BAXTER HEALTHCARE SA, a Swiss corporation with a principal place of business at Postfach 8010 Zurich, Switzerland (“BHSA”) and BAXTER HEALTHCARE CORPORATION, a Delaware corporation with a principal place of business at 1 Baxter Parkway, Deerfield, IL 60015, United States of America (“BHC” and, together with BII and BHSA, “Licensee”), on the other hand. Coherus and Licensee are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
WORK ORDER #1 PROTOCOL NUMBER: CHS-1420-02Coherus BioSciences, Inc. • May 11th, 2015 • Biological products, (no disgnostic substances)
This Work Order #1 is made and entered as of the 31st day of March, 2015 (the “Effective Date”) by and between Coherus BioSciences, Inc. (“Sponsor”) and [***] (“[***]”).
MASTER SERVICES AGREEMENTMaster Services Agreement • May 11th, 2015 • Coherus BioSciences, Inc. • Biological products, (no disgnostic substances) • California
This Master Services Agreement (the “Agreement”) is made and entered into as of February 27, 2015 (the “Effective Date”), by and between [***], with offices at [***] (together with its Affiliates, “[***]”) and Coherus BioSciences, Inc., with offices at 201 Redwood Shores Parkway Suite 200 Redwood City, CA 94065 (“Sponsor”), both hereinafter referred to as the “Parties”.
